Furthermore, the study showed that VV-IL-24 and luteolin worked together to limit the growth of liver cancer tumor xenografts as follows: On the seventh day after the last treatment, tumor tissue samples were taken from a mouse selected at random from each group. Here, IL24 is linked to neoplasm.